氟伐他汀联合阿司匹林治疗糖尿病性下肢动脉硬化闭塞症的疗效观察-老年医学专业论文.docx

下载文档 降价啦

3
0
约3.36万字
约 26页
2018-12-06 发布于上海
举报
版权申诉
保障服务

氟伐他汀联合阿司匹林治疗糖尿病性下肢动脉硬化闭塞症的疗效观察-老年医学专业论文.docx

1、本文档共26页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。

氟伐他汀联合阿司匹林治疗糖尿病性下肢动脉硬化闭塞症的疗效观察-老年医学专业论文

万方数据万方数据万方数据万方数据 from May, 2013 to May,2014 in our department, these patients were randomly divided into intervention group(60 case) and a control group(60 case), two groups were given aspirin bowel dissolving tablet (100mg qn). The intervention group received fluvastatin (40mg qn), the control group received rosuvastatin (5mg qn), then treatment of three months on the basis of conventional glycemic control. Results Blood coagulation indicators after treatment compare the two groups: FIB, DD, plasma viscosity in the intervention group were less than in the control group (P 0.05); thrombelastograph result of the comparison: the intervention group, R, K were higher than the control group, MA , CI was less than the control group (P 0.05); compliance rate comparison: the intervention group TC, TG, HDL-C, LDL-C compliance rate higher (P 0.05); carotid artery index comparison: the intervention group in CAIIMT, CAPF cases significantly less than the control group (P 0.05); ABI comparison: the intervention group are higher than the control group (P 0.05). Conclusion fluvastatin worship aspirin can improvement in patients with diabetic LEAOD plasma viscosity significantly, improve cure rate and better than rosuvastatin Keywords ： diabetes;lower-extremity arterial occlusive disease; fluvastatin; efficacy 3 目录引言········································································································································1 第 1 章研究对象及分组 ·····································································································2 1.1 研究对象·························································································································2 1.2 实验分组·························································································································2 第 2 章实验方法 ······················································································································3 2.1 治疗方法·················